Literature DB >> 30948880

Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features.

Gunjan Mangla1, Preeti Diwaker1, Priyanka Gogoi1.   

Abstract

Entities:  

Year:  2018        PMID： 30948880      PMCID： PMC6414592          DOI： 10.1007/s13193-018-0847-2

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


× No keyword cloud information.
  9 in total

1.  Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases.

Authors:  Ramya P Masand; Elizabeth D Euscher; Michael T Deavers; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

2.  Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?

Authors:  Weiwei Feng; Keqin Hua; Anais Malpica; Xianrong Zhou; Jan P A Baak
Journal:  Int J Gynecol Cancer       Date:  2013-03       Impact factor: 3.437

Review 3.  Endometrial stromal tumours revisited: an update based on the 2014 WHO classification.

Authors:  Rola H Ali; Marjan Rouzbahman
Journal:  J Clin Pathol       Date:  2015-01-16       Impact factor: 3.411

4.  Prognostic factors and treatment modalities in uterine sarcoma.

Authors:  G El Husseiny; N Al Bareedy; W A Mourad; G Mohamed; M Shoukri; J Subhi; A Ezzat
Journal:  Am J Clin Oncol       Date:  2002-06       Impact factor: 2.339

5.  Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma.

Authors:  Esther Oliva; Jean-François Egger; Robert H Young
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

Review 6.  The management of patients with uterine sarcoma: a debated clinical challenge.

Authors:  Angiolo Gadducci; Stefania Cosio; Antonella Romanini; Andrea Riccardo Genazzani
Journal:  Crit Rev Oncol Hematol       Date:  2007-08-13       Impact factor: 6.312

7.  Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.

Authors:  Arnold-Jan Kruse; Sabrina Croce; Roy F P M Kruitwagen; Robert G Riedl; Brigitte F M Slangen; Toon Van Gorp; Koen K Van de Vijver
Journal:  Int J Gynecol Cancer       Date:  2014-11       Impact factor: 3.437

8.  Endometrial stromal sarcoma: A review of the literature.

Authors:  Geetha Puliyath; M Krishnan Nair
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

9.  Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases.

Authors:  Tahereh Ashraf-Ganjoei; Nadereh Behtash; Mamak Shariat; Asamosadat Mosavi
Journal:  World J Surg Oncol       Date:  2006-08-09       Impact factor: 2.754
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.